학술논문
An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer
Document Type
Article
Author
Source
In ESMO Open April 2021 6(2)
Subject
Language
ISSN
2059-7029